FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a new, earlier unknown form of ranitidine hydrochloride exhibiting properties of H2-blocker. Invention consists that the form of ranitidine is X-ray amorphous. The X-ray amorphous form is physically stable, there is also described the method for preparing said X-ray amorphous form of earlier known crystal modifications.
EFFECT: invention provides preparing the new X-ray amorphous form of ranitidine hydrochloride exhibiting improved specific antiulcer activity.
12 cl, 1 tbl, 2 dwg
| Title |
Year |
Author |
Number |
| PHYSICALLY STABLE ROENTGEN-AMORPHOUS FORM OF RANITIDINE HYDROCHLORIDE WITH ENHANCED ANTIULCER ACTIVITY AND METHOD FOR ITS PREPARING |
1998 |
- Leonidov N.B.
- Uspenskaja S.I.
- Krasnokutskij A.B.
|
RU2203048C2 |
| NOVEL CRYSTALLINE MODIFICATION OF 5-FLUORO-1-(TETRAHYDRO-2-FURYL)-URACIL AND COMPLEX COMPOUNDS BASED ON THEREOF EXHIBITING ANTITUMOR EFFECT |
1998 |
|
RU2198171C2 |
| NANOSIZE WEAKLY CRYSTALLINE MODIFICATION OF 4-METHYL-N-[3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL]-3-[(4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO]BENAZAMIDE HYDROCHLORIDE MONOHYDRATE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON |
2013 |
- Malin Aleksandr Aleksandrovich
- Mikhajlov Oleg Rostislavovich
- Uvarov Nikolaj Aleksandrovich
|
RU2551359C1 |
| CRYSTALLINE H-MODIFICATION OF 2-AMINO-2-(2-(4-OCTYLPHENYL) ETHYL)PROPANE-1,3-DIOLE HYDROCHLORIDE, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION BASED THEREON |
2016 |
- Mikhajlov Oleg Rostislavovich
- Uvarov Nikolaj Aleksandrovich
- Malin Aleksandr Aleksandrovich
|
RU2627691C1 |
| POLYMORPHS OF 4-[2-DIMETHYLAMINO-1-(1-HYDROXYCYCLOHEXYL)ETHYL]PHENYL 4-METHYLBENZOATE HYDROCHLORIDE, METHODS FOR OBTAINING THEREOF AND APPLICATION |
2011 |
- Li Youxin
- Liu Wanhui
- Lv Yang
- Du Guanhua
- Meng Qingguo
- Yang Mina
- Zhou Fengmei
- Li Ju
- Zhang Xuemei
|
RU2576665C2 |
| WEAKLY CRYSTALLISED β-MODIFICATION OF (S)-ISOPROPYL 2-((S)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)-(PHENOXY)PHOSPHORYLAMINO)PROPANOATE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON |
2017 |
- Mikhajlov Oleg Rostislavovich
- Uvarov Nikolaj Aleksandrovich
- Malin Aleksandr Aleksandrovich
|
RU2656228C9 |
| MACROCYCLIC POLYMORPHS, COMPOSITIONS CONTAINING SUCH POLYMORPHS, AND METHODS FOR USING AND PREPARING THEM |
2008 |
- Tiu Ju-Khung
- Te Tessi Mehri
- Romero Aleks
- Itikava Esi
- Shu Eue-Kong
|
RU2478643C2 |
| CRYSTALLINE COMPLEX OF CYCLODEXTRIN WITH RANITIDIN HYDROCHLORIDE, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF |
1994 |
- Vil'Frid Fisher
- Karin Klokkers
|
RU2143896C1 |
| CRYSTALLINE FORMS OF (R)-5-[3-CHLORO-4-(2, 3-DIHYDROXYPROPOXY)BEZ[Z]ILIDEN]-2-([Z]-PROPYLIMINO)-3-o-TOLYLTHIAZOLIDIN-4-ONE |
2009 |
- Nikolas Bonkhem
- Shtefan Bukhmann
- Aleks Ehberlin
- Kristof Imboden
- Markus Fon-Raumer
|
RU2519548C2 |
| SOLID FORMS CONTAINING (-)-O-DESMETHYLVENLAFAXINE AND USE THEREOF |
2008 |
- Sizenski Majkl
- Uilkinson Kharold S.
- Snunian Dzhon
- Kim Norman
- Laflin Sharon M.
- Bekejl Rodzher P.
- Plankett Kevin
- Mauso Patrik
|
RU2477269C2 |
